导师风采
卢欣
个人信息
Personal Information
- 性别：男
- 导师类型：博导
- 职称：主任医师
- 该职称任职时间：2017
联系方式
Contact Information
- 所属院系：北京协和医院
- 所属专业：
- 邮箱 : luxin@pumch.cn
- 工作电话 : 01069152830
个人简介
Personal Profile
卢欣，男，主任医师、教授、博士生导师。1996年毕业于中国协和医科大学，获博士学位，毕业后留校，历任北京协和医院外科住院医师、基本外科主治医师、肝脏外科副主任医师、主任医师、教授。先后承担多项国家自然基金项目，参与科技部国际合作项目、卫计委行业基金等多项国家级、省部级项目。2018年被评为北京协和医院外科十佳教授。在等国际、国内著名杂志发表60余篇论文，其中近5年以通讯作者发表SCI文章23篇（包括《New England Journal of Medicine》一篇）。对肝胆系统疾病外科治疗有很深的造诣，擅长肝胆系统良、恶性肿瘤、肝内外胆管结石等疾病及肝胆系统疑难杂症的诊治。
团队简介
Team Profile
卢欣，男，主任医师、教授、博士生导师。1996年毕业于中国协和医科大学，获博士学位，毕业后留校，历任北京协和医院外科住院医师、基本外科主治医师、肝脏外科副主任医师、主任医师、教授。先后承担多项国家自然基金项目，参与科技部国际合作项目、卫计委行业基金等多项国家级、省部级项目。2018年被评为北京协和医院外科十佳教授。在等国际、国内著名杂志发表60余篇论文，其中近5年以通讯作者发表SCI文章23篇（包括《New England Journal of Medicine》一篇）。对肝胆系统疾病外科治疗有很深的造诣，擅长肝胆系统良、恶性肿瘤、肝内外胆管结石等疾病及肝胆系统疑难杂症的诊治。
- 研究方向Research Directions
肝脏恶性肿瘤的诊治
- 在校研究生Current Graduate Students
硕士研究生 0 名，博士研究生 4 名
- 科研项目Research Projects
| # | 项目名称 | 起止日期 | 金额 | 项目类型 | 本人角色 |
|---|---|---|---|---|---|
| 1 | 消化道肿瘤患者血浆游离DNA检测及临床应用 | 2016-12-01 —— 2019-12-01 | 参与在研的国家或省部级科研项目 | 参与人 |
- 发表论文Papers
| # | 论文题目 | 期刊名称 | 发表年份 | 论文署名 |
|---|---|---|---|---|
| 1 | Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery | WORLD J GASTRO ONCOL | 2019-01-01 | 通讯作者 |
| 2 | Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy | TRANSLATIONAL CANCER RESEARCH | 2020-09-01 | 通讯作者 |
| 3 | Novel nomograms based on immune and stromal scores for predicting the disease-free and overall survival for patients with hepatocellular carcinoma undergoing radical surgery | JOURNAL OF SURGICAL ONCOLOGY | 2020-12-01 | 通讯作者 |
| 4 | Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy | HEPATOBILIARY SURGERY AND NUTRITION | 2021-08-11 | 通讯作者 |
| 5 | Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study | BMC Surgery | 2022-04-17 | 通讯作者 |
| 6 | Key genes associated with tumor-infiltrating non-regulatory CD4- and CD8-positive T cells in microenvironment of hepatocellular carcinoma | BIOCHEMICAL GENETICS | 2022-01-29 | 通讯作者 |
| 7 | A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery | Scientific Reports | 2022-10-01 | 通讯作者 |
| 8 | Untargeted metabolomics reveals the role of AQP9 in nonalcoholic fatty liver disease in a mice model | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | 2022-08-10 | 通讯作者 |
| 9 | Systems biology approach reveals a common molecular basis for COVID-19 and non-alcoholic fatty liver disease (NAFLD) | EUROPEAN JOURNAL OF MEDICAL RESEARCH | 2022-11-05 | 通讯作者 |
| 10 | Diagnosis and treatment of liver metastases of parathyroid carcinoma | Frontiers in Endocrinology | 2022-10-11 | 通讯作者 |
| 11 | Causal relationships between metalloproteinases and estrogen receptor-negative breast cancer: a bidirectional mendelian randomization study | Scientific Reports | 2023-05-15 | 通讯作者 |
| 12 | Research on liquid biopsy for cancer: A bibliometric analysis | HELIYON | 2023-05-01 | 通讯作者 |
| 13 | Prognostic value of SAT volume and density for predicting the outcome of patients with unresectable HCC treated with lenvatinib plus anti-PD-1 antibodies | American Journal of Cancer Research | 2023-04-13 | 通讯作者 |
| 14 | Hyperprogressive disease in patients suffering from solid malignancies treated by immune checkpoint inhibitors: A systematic review and meta-analysis. | Frontiers in Oncology | 2022-08-03 | 通讯作者 |
| 15 | Evolution of associating liver partition and portal vein ligation for staged hepatectomy from 2012 to 2021: A bibliometric analysis. Review | International Journal of Surgery | 2022-05-03 | 通讯作者 |
| 16 | The efficacy and safety of chimeric antigen receptor T cells in digestive system cancers:a systematic review and meta-analysis | Annals of Translational Medicine | 2022-02-18 | 通讯作者 |
| 17 | Safety，feasibility，and efficacy of associating liver partition and portal vein ligation for staged hepatectomy in treating hepatocellular carcinoma：a systematic review | Annal of Translational Medicine | 2020-10-01 | 通讯作者 |
| 18 | Surgical treatment of primary hepatocellular carcinoma with intrapericardial tumor thrombus without extracorporeal circulation | HEPATOBILIARY SURGERY AND NUTRITION | 2019-08-01 | 通讯作者 |
| 19 | Fruits and vegetables consumption and the risk of gallstone diasease A systematic review and meta-analysis | MEDICINE | 2019-07-01 | 通讯作者 |
| 20 | Primary yolk sac tumour of the liver: A diagnostic pitfall | EUROPEAN JOURNAL OF CANCER | 2022-01-01 | 通讯作者 |
| 21 | Letter to the Editor: Is Aspirin a Drug or Just a Marker for Biliary Cancer? | Hepatology | 2021-11-01 | 通讯作者 |
| 22 | Comment on‘‘Preoperative Single dose Methylprednisolone Prevents Surgical Site Infections After Major Liver Resection: A Randomized Controlled Trial’’ Preoperative Single-dose Methylprednisolone Prevents Surgical Site Infections or Protects the Hepatic Function | Annals of surgery | 2021-11-30 | 通讯作者 |
| 23 | Letter to the editor: For the core set of the bile lipidome and meta-proteome signature, repeatability is the key | HEPATOLOGY | 2022-04-28 | 通讯作者 |
| 24 | Letter to the Editor: Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in the Real World. | HEPATOLOGY | 2022-05-23 | 通讯作者 |
| 25 | Letter to the editor: The role of aquaporin 9 in modeling of ornithine transcarbamylase deficiency | HEPATOLOGY | 2022-04-01 | 通讯作者 |
| 26 | Comment on “Preoperative Single-Dose Methylprednisolone Prevents Surgical Site Infections After Major Liver Resection: A Randomized Controlled Trial.” | ANNALS OF SURGERY | 2021-04-30 | 通讯作者 |
| 27 | Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study | EUROPEAN JOURNAL OF MEDICAL RESEARCH | 2023-07-10 | 通讯作者 |
| 28 | Lenvatinib combined with PD-1 inhibitor plus Gemox chemotherapy versus plus HAIC for advanced biliary tract cancer | INTERNATIONAL IMMUNOPHARMACOLOGY | 2024-05-10 | 通讯作者 |
- 科研获奖Research Awards
无
- 研究成果Research Findings
| # | 成果类型 | 项目/专利/新品种名称 |
|---|---|---|
| 1 | 获得省部级及以上科研奖励 | 以MDT为基础的肝胆系恶性肿瘤精准免疫治疗体系的建立与推广 |